Federation Des Caisses Desjardins Du Quebec Greenwich Life Sciences, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 100 shares of GLSI stock, worth $1,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,204
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GLSI
# of Institutions
39Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA275KShares$3.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.61 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL87.4KShares$1.05 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.05 Million0.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $155M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...